IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.768
NA - Nord America 5.046
AS - Asia 3.383
SA - Sud America 1.149
Continente sconosciuto - Info sul continente non disponibili 570
AF - Africa 116
OC - Oceania 2
AN - Antartide 1
Totale 17.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.904
RU - Federazione Russa 3.638
SG - Singapore 1.398
BR - Brasile 980
CN - Cina 926
IE - Irlanda 804
IT - Italia 652
SE - Svezia 601
HK - Hong Kong 400
VN - Vietnam 228
DE - Germania 200
FR - Francia 197
GB - Regno Unito 137
PL - Polonia 124
IN - India 109
UA - Ucraina 105
FI - Finlandia 103
AT - Austria 78
BD - Bangladesh 63
CA - Canada 59
AR - Argentina 51
MX - Messico 47
IQ - Iraq 37
TR - Turchia 32
MA - Marocco 30
ZA - Sudafrica 30
ID - Indonesia 29
BE - Belgio 28
NL - Olanda 28
EC - Ecuador 26
CO - Colombia 22
UZ - Uzbekistan 22
JP - Giappone 20
VE - Venezuela 19
ES - Italia 17
PK - Pakistan 16
UY - Uruguay 15
PY - Paraguay 13
SA - Arabia Saudita 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
CL - Cile 10
CZ - Repubblica Ceca 10
MY - Malesia 9
DZ - Algeria 8
GE - Georgia 8
CR - Costa Rica 7
JM - Giamaica 7
PE - Perù 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
PH - Filippine 6
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
LB - Libano 5
AL - Albania 4
BG - Bulgaria 4
CH - Svizzera 4
GR - Grecia 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
NI - Nicaragua 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
EU - Europa 3
HN - Honduras 3
KR - Corea 3
KW - Kuwait 3
NP - Nepal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
MD - Moldavia 2
MU - Mauritius 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
DK - Danimarca 1
EE - Estonia 1
GP - Guadalupe 1
IR - Iran 1
Totale 16.452
Salva come PNG Salva come JPEG
Città #
Moscow 1.058
Dublin 804
Ashburn 757
Singapore 741
Chandler 547
Nyköping 433
Hong Kong 399
Dallas 361
Beijing 342
Messina 262
Jacksonville 230
San Jose 200
Council Bluffs 188
The Dalles 134
Princeton 127
Warsaw 122
Medford 114
Lauterbourg 110
Los Angeles 100
Dearborn 91
Des Moines 91
Cambridge 81
São Paulo 74
Ann Arbor 71
Ho Chi Minh City 71
Vienna 71
Buffalo 58
New York 57
Redondo Beach 51
Tianjin 48
Hanoi 47
Santa Clara 46
Boardman 39
Frankfurt am Main 34
Lancaster 33
Rio de Janeiro 33
Guangzhou 31
Munich 31
Jinan 30
San Mateo 30
Orem 26
Hyderabad 25
Montreal 25
Brussels 24
Belo Horizonte 22
Rome 22
Stockholm 21
Tashkent 21
Aversa 20
Curitiba 20
Brooklyn 19
Chicago 19
Houston 19
Amsterdam 18
Brasília 18
Tokyo 18
Wilmington 18
Atlanta 17
San Francisco 17
Baghdad 16
Campinas 16
Mexico City 16
Porto Alegre 16
Pune 16
Milan 15
Seattle 15
Shanghai 15
Shenzhen 15
Johannesburg 14
London 14
Phoenix 14
Shenyang 14
Chennai 13
Denver 13
Woodbridge 13
Boston 12
Catania 12
Columbus 12
Düsseldorf 12
Montevideo 12
Montpellier 12
Mumbai 12
Casablanca 11
Palermo 11
Taizhou 11
Augusta 10
Dong Ket 10
Guarulhos 10
Haikou 10
Helsinki 10
Nanjing 10
Nuremberg 10
Uberlândia 10
Zhengzhou 10
Bari 9
Biên Hòa 9
Da Nang 9
Dhaka 9
Hebei 9
Manaus 9
Totale 9.032
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 247
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 207
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 207
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 192
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 189
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 179
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 172
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 169
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 169
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 166
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 165
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 163
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 162
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 161
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 160
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 159
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 159
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 158
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 157
Development of novel amides as non covalent inhibitors of immunoproteasome 155
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 154
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 154
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 153
Design and synthesis of novel isoxazole-based HDAC inhibitors 153
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 149
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 149
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 149
Falcipain-2 inhibitors 148
Evaluation of curcumin irreversibility 148
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 146
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 145
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 145
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 144
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 143
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 142
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 142
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 141
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 141
Composti antitumorali 141
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 139
Role of the microbiota in hematologic malignancies. 139
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 138
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications 136
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 136
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 134
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 134
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 133
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 131
Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives 129
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 129
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 127
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 126
Development of peptidomimetic boronates as proteasome inhibitors 125
Development of peptidomimetic boronates as proteasome inhibitors 125
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 125
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 125
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 124
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 124
Glutamate Binding-Site Ligands of NMDA Receptors 122
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 122
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 122
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 122
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 120
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 119
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 118
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 118
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 118
Monoclonal antibodies: the greatest resource to treat multiple myeloma 116
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 116
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 115
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 115
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 115
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 115
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 115
A proteomic platform unveils the brain glycogen phosphorylase as a potential metabolic target for glioblastoma multiforme 115
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 114
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 114
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 114
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 112
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 111
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 111
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 110
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 109
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 108
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 105
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 105
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 103
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 102
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 102
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 101
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 101
Recent Advances in Nanotherapeutics for Multiple Myeloma 100
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 99
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 98
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 98
Development of novel amides as noncovalent inhibitors of immunoproteasome 97
Novel peptidomimetic cysteine protease inhibitors as antimalarial agents 96
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 96
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 95
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 95
Totale 13.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 104 6 48 14 6 65 25 7 53 133 299
2022/20232.281 182 201 103 179 141 229 36 148 959 4 76 23
2023/2024589 69 72 41 143 55 48 6 8 3 62 33 49
2024/20252.463 41 21 44 157 92 56 75 460 676 175 236 430
2025/20268.358 306 531 538 656 689 1.792 1.082 1.054 1.018 366 134 192
2026/2027483 143 340 0 0 0 0 0 0 0 0 0 0
Totale 17.035